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Abstract
BACKGROUND: Soil-transmitted helminths (STHs) infection (i.e., Ascaris lumbricoides, Trichuris trichiura, and 
hookworm) are commonly found as a single infection as well as a mixture of the three kinds of helminths that requires 
a broad anthelmintic spectrum. Some study revealed that combination of anthelmintic provides better efficacy.
AIM: The objective of the study was to compare the efficacy of combination treatment of albendazole-mebendazole, 
albendazole-pyrantel pamoate, and mebendazole alone in treating STHs infection as well as the rate of reinfection 
post-treatment.
METHODS: In 2018, a randomized controlled trial was conducted in Batubara district, North Sumatera. School-aged 
children diagnosed for STH were randomly allocated to (1) albendazole-mebendazole; (2) albendazole-pyrantel 
pamoate; or (3) mebendazole treatment groups. Here, we report the efficacy (cure rates [CRs] and egg-reduction 
rates [ERR]) and reinfection rates determined 12 weeks post-treatment. Chi-square test was used to compare the 
drug efficacy and reinfection rate between three groups.
RESULTS: A total of 309 children complete baseline and follow-up data. The efficacy was determined after 4 weeks 
post-treatment albendazole-pyrantel pamoate showed a significant higher efficacy against A. lumbricoides (CR: 
93.5%; ERR: 100%) and T. trichiura (CR: 81.4%; ERR: 99%). For hookworm infection, results showed higher efficacy 
between the three groups after treatment. The reinfection rates 12 weeks after treatment for A. lumbricoides infection 
(Group 1: 3.1%; 2: 3%; 3: 1.3%) with p > 0.05 and for T. trichiura infection (Group 1: 19.2%; 2: 25%; 3: 1.5%) with 
p < 0.05.
CONCLUSION: This study showed the excellent efficacy of an albendazole-pyrantel pamoate combination against 
STHs infections. The highest reinfection rate was found in albendazole-pyrantel pamoate group for T. trichiura 
infection.
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Introduction
Soil-transmitted helminths (STH) infections 
are one of the common chronic human infections in the 
world caused by a group of parasitic nematode worms. 
Infections occur through contact with parasite, eggs, 
or larvae that thrive in the warm and moist soil of the 
world’s tropical and subtropical countries [1] The three 
main groups of STHs that infect humans are Ascariasis 
lumbricoides, Trichuris trichiura, and hookworm 
(Ancylostoma duodenale and Necator americanus) [2].
The prevalence of STHs infection in Indonesia 
in 2009 showed that 31.8% of children suffered from 
STH infections and survey in 2005 found that the 
prevalence was 30% [3], [4]. The prevalence of STH 
infection in Sumatera Utara in 2012 was 32.3% [5], and 
the prevalence in Medan in 2008 was 73% [6]. Study 
in Suka Village, North Sumatera, Indonesia, in 2004 
found that the prevalence was 91.3% [7].
STHs infection is commonly found as a 
single or mixture of three groups of STH [8]. There are 
some anthelmintics such as albendazole, levamisole, 
mebendazole, and pyrantel pamoate that are effective 
against STH infections with their strength and weakness. 
In implementation, most of STH infection control 
programs only use benzimidazole such as albendazole 
and mebendazole [9]. Although one-dose treatment with 
both drugs shows high efficacy against A. lumbricoides, 
but only albendazole cures a satisfactory proportion 
of hookworm infections. Both drugs show low efficacy 
against T. trichiura [10]. The combination of albendazole-
mebendazole and albendazole-oxantel pamoate has 
emerged as potential therapies against STH infections 
in a series of randomized controlled trials [11], [10]. 
These drug combinations were well tolerated and 
improved the proportions of patients cured of T. trichiura, 
A. lumbricoides, and hookworm infections. However, 
drug efficacy is affected by myriad factors (e.g., baseline 
infection intensity, parasite strain, host factors, and the 
diagnostic approach used), the findings were difficult 
to compare and interpret [10], [12], [13]. This study 
undertook a randomized controlled trial to compare the 
efficacy and safety of albendazole-mebendazole and 
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albendazole-pyrantel pamoate, with standard treatment 
(one-dose mebendazole), to identify the intervention 
with the greatest efficacy against STH in elementary 
school students.
Methods
This study conducted a randomized, controlled, 
OpenTrial from July to December 2018 in three primary 
schools, in Batubara district, North Sumatera.
Inclusion criteria
Children between 6 and 12 years of age 
whose stool samples were positive for single infection 
or co-infection with either A. lumbricoides, T. trichiura, 
or and hookworm were considered eligible.
Exclusion criteria
Children who have used anthemintics 1 month 
before the study were excluded from the study.
Ethical approval
Ethical approval was obtained from the Health 
Research Ethics Committee of the Faculty of Medicine, 
University of Sumatera Utara. Before the commencement 
of the study, permission was obtained from the school 
authority. The parents or guardians of the children were 
invited to the school and informed about the study 
procedure, including potential benefits and risks. Written 
informed consent was obtained from the parents or 
legal guardians and verbal assent from the participating 
children. Before treatment, the children were examined 
for clinical signs and symptoms of any existing disease 
and their weight and height were measured.
Study protocol
Children were randomly assigned, with the 
use of randomization table, to receive one of three 
treatments: Albendazole 400 mg plus mebendazole 
500 mg, albendazole 400 mg plus pyrantel pamoate 
10 mg/kg, or 500 mg of mebendazole. Children, study-
site investigators, and laboratory scientists were aware 
of the randomized study groups. After 4 and 12 weeks 
of treatment, stool samples were collected from the 
children for the diagnosis of STH infections. Stool 
samples were transferred to the laboratory and Kato-
Katz thick smears were examined by skilled laboratory 
scientists for eggs of A. lumbricoides, T. trichiura, and 
hookworm. At the end of the study, all children remaining 
infected received treatment.
Treatment efficacy was assessed 4 weeks 
after treatment. The efficacy was assessed using cure 
rates (CRs) and egg reduction rates (ERR). CR was 
defined as the percentage of individuals who became 
helminth egg negative after treatment with anthelminthic 
drugs [10], [14]. Reinfection rates were defined as 
children positive at baseline, negative 12 weeks, and 
positive 12 weeks post-treatment [15].
Statistical analysis
The Chi-square test was used to compare 
the variable between the treatment group and CRs, 
ERR, and reinfections. Data processing was performed 
using Statistical Package for the Social Sciences for 
Windows (SPSS) version 24.0, 2016 with p < 0.05 was 
significance and 95% confidence interval.
Results
Study participants
In total, 840 children who were invited to 
participate, 676 had complete baseline data. The 
prevalence of STHs infection was 45.7% (309/676). We 
randomly assigned 309 eligible children infected with 
STHs between, to one of the three treatment groups 
(Figure 1). Demographic and baseline laboratory 
characteristics of the 309 children included in the 
analysis are summarized in Table 1. Treatment groups 
were well balanced at baseline in terms of age, sex, 
and nutritional status.
Randomized
676 screened
840 students
367 negative STH egg
164 no stool sample
309 positive stool sample
Group 1:
Albendazole 400 mg
Mebendazole 500 mg
single dose
(n 110)
Group 2:
Albendazole 400 mg
Pyrantel pamoate 10mg/BW
single dose (n = 102)
Group 3:
Mebendazole 500 mg
single dose (n = 97)
4 weeks post treatment (110)
Negatif : 76
Positif : 34
4 weeks post treatment (102)
Negatif : 84
Positif: 18
4 weeks post treatment (97)
Negatif : 49
Positif: 48
12 weekspost treatment (49)
Reinfection : 2
12 weeks post treatment (84)
Reinfection: 24
12 weeks post treatment (76)
Reinfection :18
Figure 1: Study flow chart
CRs and ERR among 309 children with 
STHs infection are shown in Table 2. Treatment with 
albendazole-pyrantel pamoate resulted in a significantly 
higher CR among children with A. lumbricoides and 
T. trichiura infection than did albendazole-mebendazole 
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and mebendazole (A. lumbricoides 93.5% vs. 57.1% 
vs. 27.6%, p < 0.05; T. trichiura 81.4% vs. 69.2% 
vs. 65.6%, p < 0.05). We observed no significant 
differences between the three-drug combinations with 
respect to CRs in hookworm infection. Mebendazole 
monotherapy resulted in a significant lower CR than 
combination drug, especially in A. lumbricoides and 
T. trichiura infection.
Table 2: Comparison of efficacy between the three groups 
after treatment
Efficacy (%) Albendazole-
mebendazole 
(n = 110)
Albendazole-
pyrantel pamoate 
(n = 102)
Mebendazole 
(n = 97)
P*
Efficacy of STH 69 82 50 0.001
CRs
A. lumbricoides 57.1 93.5 27.6 0.001
T. trichiura 69.2 81.4 65.6 0.037
Hookworm 91.7 100.0 87.5 0.605
ERRs
A. lumbricoides 100.0 100.0 96.6 0.357
T. trichiura 99.0 99.0 100.0 0.625
Hookworm 100.0 100.0 87.5 0.187
*The Chi-square test. A. lumbricoides: Ascaris lumbricoides, T. trichiura: Trichuris 
trichiura, STH: Soil-transmitted helminth, CRs: Cure rates, ERR: Egg-reduction rates.
After 12 weeks post-treatment, 44 out of 201 
(21.9%) children were reinfected with A. lumbricoides 
and T. trichiura. For A. lumbricoides, the prevalence at 
baseline was 28.5% by design. This study observed 
that 7 of the 88 children (8%) were reinfected with 
A. lumbricoides 12 weeks after treatment. For 
T. trichiura infection, 37 of the 293 (12.7%) cured 
children were found to be reinfected 12 weeks after 
being treated. All reinfections were of mild intensity. 
There was a significant difference in the reinfection 
level of T. trichiura infection between three treatment 
groups, but there was no  significant difference in 
A. lumbricoides reinfections (Table 3).
Table 3: The incidence of reinfection after drug administration
Reinfection (%) Albendazole-
mebendazole (n = 110)
Albendazole-pyrantel 
pamoate (n = 102)
Mebendazole 
(n = 97)
p*
Reinfection, n (%)
A. lumbricoides 3 (3.1) 3 (3.1) 1 (1.3) 0.786
T. trichiura 15 (19.2) 21 (25) 1 (1.5) 0.001
*The Chi-square test. A. lumbricoides: Ascaris lumbricoides, T. trichiura: Trichuris trichiura.
Discussion
The prevalence of STHs infection in this study 
was 45.7%, consisting of A. lumbricoides 28.5%, 
T. trichiura 95.1%, and hookworm 11.3%. However, the 
prevalence was lower than the reports from the previous 
study in Medan (2008) was 73% [6], in Kabupaten Karo 
(2002) was 95.4% [14], and 91.3% (2004) [7]. The 
prevalence of STHs infection observed in this study was 
lower than the previous study which may be as a result 
of the helminthiasis control program by government 
targeted at preschoolers (1–4-year-old) and elementary 
school-aged children (5–12-year-old) [3]. T. trichiura 
infection in our study was higher than the other helminth 
infections. It may result from the use of albendazole in 
the helminthiasis control program, which is T. trichiura 
is less sensitive to single-dose albendazole [3], [8], [16].
The treatment for STH single infection has 
good results, but the treatment for mixed infections 
shows unsatisfactory results [9]. The meta-analysis 
comparing CRs of single dosed drugs have various 
results [11].
Four weeks after treatment, CRs of 
A. lumbricoides achieved with the combination 
of albendazole-pyrantel pamoate were 93.5%, 
albendazole-mebendazole was 57.1%, and 
mebendazole was 27.6%. In earlier studies, CR 
of albendazole-oxantel pamoate, albendazole-
mebendazole, and mebendazole was 97.7%, 100%, 
and 95.4%, respectively [15]. Another study comparing 
the CRs after albendazole-oxantel pamoate and 
mebendazole treatments also demonstrates high CRs, 
that is, 94.4% and 91.2%, respectively [10].
Albendazole-pyrantel pamoate had greater 
efficacy against T trichiura compared with the established 
standard treatment of one-dose mebendazole. This 
study shows that the CRs of T. trichiura after treated 
with albendazole-pyrantel pamoate were 81.4%. 
Previous studies of combinations albendazole-
oxantel pamoate documented high efficacy against 
T. trichiura [10], [12], [15]. The CRs resulted in the 
previous study are lower than this study, but that result 
was the highest CRs among the treatment groups in 
that study.
Albendazole-pyrantel pamoate treatment 
shows high CRs from A. lumbricoides and T. trichiura 
because these drugs have different pharmacokinetics 
and pharmacodynamics, meaning that pyrantel 
pamoate will disable helminth, and active metabolism 
of albendazole will kill the worms, eggs, and 
larva [13], [17], [18], [19]. The CRs of albendazole-
mebendazole against A. lumbricoides and T. trichiura 
were good in this study. It is resulted by the mechanism 
of drugs, mebendazole is an active component that will 
contact with the worm, followed with the metabolism of 
albendazole, so the worm will have long contact with 
drugs [14].
Table 1: Baseline subject characteristics
Characteristics Albendazole-
mebendazole 
 (n = 110)
Albendazole-
pyrantel pamoate 
(n = 102)
Mebendazole 
 (n = 97)
Age (year), mean (SD) 8.3 (1.58) 8.9 (1.8) 8.8 (1.63)
Nutritional status, n (%)
Severe malnutrition 6 (5.5) 3 (2.9) 1 (1.03)
Mild malnutrition 52 (47.3) 45 (44.1) 35 (36.0)
Well nourish 47 (42.7) 45 (44.1) 51 (52.5)
Overweight 2 (1.8) 5 (4.9) 5 (5.1)
Obesity 3 (2.7) 4 (3.9) 5 (5.1)
Sex, no (%)
Male 56 (35.7) 54 (34.4) 47 (29.9)
Female 54 (35.5) 48 (31.6) 50 (32.9)
Infection, no (%)
A. lumbricoides 28 (25.5) 31 (30.4) 29 (29.9)
T. trichiura 103 (94.5) 97 (95.1) 93 (95.9)
Hookworm 12 (10.9) 15 (14.7) 8 (8.2)
EPG feces, median (range)
A. lumbricoides 831 (132–62424) 1512 (192–11592) 1342 (97–38808)
T. trichiura 763 (48–19103) 726 (48–9786) 772 (72–9657)
Hookworm 21 (9–97) 18 (8–89) 16 (6–39)
Multiple infection, no (%)
Double infection 32 (29.1) 41 (40.2) 33 (34.0)
Triple infection 1 (0.9) 0 (0.0) 0 (0.0)
A. lumbricoides: Ascaris lumbricoides, T. trichiura: Trichuris trichiura.
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The CRs of Hookworm showed the greatest 
efficacy in our study. The CRs achieved with the 
combination of albendazole-mebendazole were 
91.7%, albendazole-pyrantel pamoate was 100%, and 
mebendazole was 87.5%. This result was different 
with the previous study. In an earlier study, CRs of 
albendazole-mebendazole were 48.8%, albendazole-
oxantel pamoate was 48%, and mebendazole was 
24.4% [12]. The different can cause of large of sample 
and parasite strains at the two study sites might account 
for this contradictory finding.
A study at Tanzania in 2015 that assessed egg 
reduction in STHs infections reported that reduction 
of T. trichiura and hookworm eggs after treated with 
mebendazole was unsatisfactory [12]. Egg reduction in 
our study was good for all treatment groups. Although 
mebendazole had very poor CRs in this study, it still has 
great efficacy to reduce the eggs.
In our study, reinfection was found in 
A. lumbricoides and T. trichiura, but not in hookworms. 
It can be caused by the life cycle of hookworm that 
can survive for a few weeks on the soil under suitable 
conditions [20]. A. lumbricoides and T. trichiura are 
very durable in the right environmental condition 
and infective for several months, so individuals 
can be reinfected from the eggs that survive in the 
environment [21]. There are significant differences in 
reinfection of T. trichiura between the three treatment 
groups. In our study, the reinfection rate of T. trichiura 
12 weeks post-treatment for albendazole-pyrantel 
pamoate was 25%, albendazole-mebendazole was 
19.2%, and mebendazole was 19.2%. In another 
study, the reinfection rate in mebendazole group was 
50%, albendazole-oxantel pamoate was 30.9%, and 
albendazole-mebendazole was 22.2% [15].
The reinfection rate in our study was not as 
high as in the previous study, probably due to various 
factors that influence the incidence of STH reinfection. 
STH infection is closely related to poverty, poor hygiene, 
lack of clean water access, and poor sanitation [22]. 
These factors also influence reinfection. However, the 
factors that influence STH reinfection are not report in 
our study.
Conclusion
We identified two combination therapies 
against STHs that have significantly higher efficacy 
than the standard treatment of mebendazole alone: 
Albendazole plus pyrantel pamoate and albendazole 
plus mebendazole. On the one hand, the combination 
including pyrantel pamoate cured a larger proportion of 
patients than the combination with mebendazole. This 
combination could become a key element in controlling 
STH infections, especially in highly endemic settings. 
Further, trials should evaluate reinfection rates with 
pyrantel pamoate 6 and 12 months after treatment and 
ideally after several rounds of treatment.
The reinfection rate observed for A. lumbricoides 
and T. trichiura is worrying. This finding supports the 
necessity of integrated control approaches, including 
regular treatment, improved sanitation and health 
education, to reduce the burden of STH infections.
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